This series of seminars, begun in 2013, brings together distinguished experts, policymakers, and thought leaders to discuss the latest developments, challenges, and innovations shaping clinical research and regulatory frameworks in the UK.

Under the expert chairmanship of Dr. Virginia Acha, Associate Vice President and Global Lead for Global Regulatory Policy at MSD, this programme will provide invaluable insights into key areas, including regulatory updates, advances in decentralized clinical trials (DCTs), equitable approaches to health research, and cutting-edge in silico trial methodologies.

As the UK adapts to a rapidly changing healthcare environment, these discussions are more crucial than ever. From examining the legacy and future of the MHRA to exploring projects like the Trials@Home RADIAL case study, today’s sessions are designed to equip professionals with the knowledge and strategies needed to advance clinical research responsibly and sustainably.

We encourage active participation through questions and dialogue throughout the day. Together, let’s explore how we can drive innovation while maintaining the highest standards of patient care and scientific integrity.

We hope to meet you at the Royal Society of Medicine, London, for this important seminar focused on the evolving landscape of clinical research in the UK.

Course Fee:
CCRA Members: £300.00
EMIG Members: £375.00
Non-members: £450.00